MEDAD NEWS: UNSCRIPTED SCRUTINY

The battle for the hearts, minds and prescription pads of physicians treating targeted patients has always been challenging, but competitive pressures have never been more intense. Impending patent expirations threaten to expose billions of dollars in branded products to generic erosion. Mounting regulatory pressures, feverish political climate and lukewarm economic conditions place even greater restrictions…